These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10506648)

  • 21. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers.
    Venkataprasad N; Coombes AG; Singh M; Rohde M; Wilkinson K; Hudecz F; Davis SS; Vordermeier HM
    Vaccine; 1999 Apr; 17(15-16):1814-9. PubMed ID: 10217578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microencapsulation of antigens using biodegradable polyesters: facts and phantasies.
    Kissel T; Koneberg R; Hilbert AK; Hungerer KD
    Behring Inst Mitt; 1997 Feb; (98):172-83. PubMed ID: 9382738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles.
    O'Hagan DT; Ott GS; Van Nest G
    Mol Med Today; 1997 Feb; 3(2):69-75. PubMed ID: 9060004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease.
    Negash T; Liman M; Rautenschlein S
    Vaccine; 2013 Aug; 31(36):3656-62. PubMed ID: 23777953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.
    Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z
    Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
    Jones DH; Partidos CD; Steward MW; Farrar GH
    Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens.
    Saini V; Verma SK; Murthy PK; Kohli D
    Vaccine; 2013 Aug; 31(38):4183-91. PubMed ID: 23827312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC; Yeh MK; Coombes AG; Davis SS
    Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules.
    Saini V; Verma AK; Kushwaha V; Joseph SK; Murthy PK; Kohli D
    Drug Deliv; 2014 May; 21(3):233-41. PubMed ID: 24171405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
    Tom JW; Debenedetti PG
    Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK; Muthukumaran T; Panda AK
    Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
    Davis SS
    Vaccine; 2006 Apr; 24 Suppl 2():S2-7-10. PubMed ID: 16823907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M
    Iran J Basic Med Sci; 2018 Feb; 21(2):116-123. PubMed ID: 29456807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.